These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 18832433

  • 1. Low striatal serotonin transporter protein in a human polydrug MDMA (ecstasy) user: a case study.
    Kish SJ, Fitzmaurice PS, Chang LJ, Furukawa Y, Tong J.
    J Psychopharmacol; 2010 Feb; 24(2):281-4. PubMed ID: 18832433
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
    Wang X, Baumann MH, Xu H, Rothman RB.
    Synapse; 2004 Sep 15; 53(4):240-8. PubMed ID: 15266556
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Serotonin transporter expression is not sufficient to confer cytotoxicity to 3,4-methylenedioxymethamphetamine (MDMA) in vitro.
    Hayat S, Williams RJ, Rattray M.
    J Psychopharmacol; 2006 Mar 15; 20(2):257-63. PubMed ID: 16510483
    [Abstract] [Full Text] [Related]

  • 8. Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines.
    Xie T, Tong L, McLane MW, Hatzidimitriou G, Yuan J, McCann U, Ricaurte G.
    Neuropsychopharmacology; 2006 Dec 15; 31(12):2639-51. PubMed ID: 16452989
    [Abstract] [Full Text] [Related]

  • 9. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity.
    Biezonski DK, Meyer JS.
    J Neurochem; 2010 Feb 15; 112(4):951-62. PubMed ID: 20002520
    [Abstract] [Full Text] [Related]

  • 10. Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects.
    Reneman L, de Win MM, van den Brink W, Booij J, den Heeten GJ.
    J Psychopharmacol; 2006 Mar 15; 20(2):164-75. PubMed ID: 16510475
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. MDMA-induced serotonergic neurotoxicity enhances aggressiveness in low- but not high-aggressive rats.
    Wallinga AE, ten Voorde AM, de Boer SF, Koolhaas JM, Buwalda B.
    Eur J Pharmacol; 2009 Sep 15; 618(1-3):22-7. PubMed ID: 19616536
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
    Verrico CD, Miller GM, Madras BK.
    Psychopharmacology (Berl); 2007 Jan 15; 189(4):489-503. PubMed ID: 16220332
    [Abstract] [Full Text] [Related]

  • 17. High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain.
    Rothman RB, Jayanthi S, Wang X, Dersch CM, Cadet JL, Prisinzano T, Rice KC, Baumann MH.
    Synapse; 2003 Dec 01; 50(3):233-9. PubMed ID: 14515341
    [Abstract] [Full Text] [Related]

  • 18. In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p-methoxyamphetamine (PMA), but not 3,4-methylenedioxymethamphetamine (MDMA), leads to long-lasting deficits in serotonin transporter function.
    Callaghan PD, Owens WA, Javors MA, Sanchez TA, Jones DJ, Irvine RJ, Daws LC.
    J Neurochem; 2007 Feb 01; 100(3):617-27. PubMed ID: 17181558
    [Abstract] [Full Text] [Related]

  • 19. Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region?
    Kish SJ, Furukawa Y, Chang LJ, Tong J, Ginovart N, Wilson A, Houle S, Meyer JH.
    Nucl Med Biol; 2005 Feb 01; 32(2):123-8. PubMed ID: 15721757
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.